Biomarker detection has become an integral part of both disease detection and treatment. The detection of biomarkers in pre-symptomatic patients leads to the ability to start treatment in early stages of disease, thus drastically improving outcomes. Furthermore, continued monitoring of biomarkers can tell us how a patient is responding to the treatment, allowing for changes to be made if needed.
From biomarker assay development to primary and secondary screening, PerkinElmer offers a complete portfolio for your biomarker detection needs.
For research use only. Not for use in diagnostic procedures.